Financing
Net change in short-term borrowings
Pfizer Net change in short-term borrowings increased by 101.2% to $6.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 100.4%, from -$1.49B to $6.00M. Over 3 years (FY 2021 to FY 2024), Net change in short-term borrowings shows a downward trend with a 199.9% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase indicates a reliance on short-term credit to fund operations, while a decrease suggests the repayment of short-term liabilities.
Detailed definition
This metric measures the net change in short-term debt obligations, such as commercial paper or lines of credit, during...
Peer comparison
Peers use short-term borrowing as a flexible tool to manage seasonal cash flow needs; high reliance can indicate tighter liquidity.
Metric ID:
cf_short_term_borrowings_netHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$474.00M | $764.00M | -$361.00M | -$220.00M | $599.00M | $491.00M | -$1.09B | $226.00M | -$204.00M | -$128.00M | $3.27B | -$2.04B | $938.00M | -$1.49B | $0.00 | -$386.00M | -$517.00M | $6.00M |
| QoQ Change | — | +261.2% | -147.3% | +39.1% | +372.3% | -18.0% | -322.4% | +120.7% | -190.3% | +37.3% | >999% | -162.4% | +146.0% | -258.7% | +100.0% | — | -33.9% | +101.2% |
| YoY Change | — | — | — | — | +226.4% | -35.7% | -202.5% | +202.7% | -134.1% | -126.1% | +399.2% | <-999% | +559.8% | <-999% | -100.0% | +81.1% | -155.1% | +100.4% |
Range-$2.04B – $3.27B
CAGR-64.2%
Avg YoY Growth-89.2%
Median YoY Growth-67.9%
Net change in short-term borrowings at Other Companies
Frequently Asked Questions
- What is Pfizer's net change in short-term borrowings?
- Pfizer (PFE) reported net change in short-term borrowings of $6.00M in Q3 2025.
- How has Pfizer's net change in short-term borrowings changed year-over-year?
- Pfizer's net change in short-term borrowings increased by 100.4% year-over-year, from -$1.49B to $6.00M.
- What is the long-term trend for Pfizer's net change in short-term borrowings?
- Over 3 years (2021 to 2024), Pfizer's net change in short-term borrowings has grown at a 199.9% compound annual growth rate (CAGR), from -$96.00M to -$2.59B.
- What does net change in short-term borrowings mean?
- The net increase or decrease in debt that must be repaid within one year.